Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
CompARE: Escalating Treatment of Intermediate and High-risk Oropharyngeal Cancer (OPC)Head and Neck Neoplasms, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, neoplasm, otorhinolaryngologic diseaseActive, not recruitingPhase 32026-05-07NCT04116047

3 results · Page 1 of 1

Swipe the table sideways for more columns.

38 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Aberdeen Royal InfirmaryAberdeenUnited Kingdom1
Addenbrooke's HospitalCambridgeUnited Kingdom40
Aintree University HospitalLiverpoolUnited Kingdom12
Beatson West of Scotland Cancer CentreGlasgowUnited Kingdom39
Belfast City HospitalBelfastUnited Kingdom24
Bradford Royal InfirmaryBradfordUnited Kingdom4
Bristol Haematology and Oncology CentreBristolUnited Kingdom1
Castle Hill HospitalCottinghamUnited Kingdom3
Cheltenham General HospitalCheltenhamUnited Kingdom6
Christie HospitalManchesterUnited Kingdom12
Churchill HospitalOxfordUnited Kingdom8
Clatterbridge Cancer CentreMetropolitan Borough of WirralUnited Kingdom14
Colchester General HospitalColchesterUnited Kingdom3
Derriford HospitalPlymouthUnited Kingdom27
Freeman HospitalNewcastle upon TyneUnited Kingdom5
James Cook University HospitalMiddlesbroughUnited Kingdom3
Leicester Royal InfirmaryLeicesterUnited Kingdom1
Musgrove Park HospitalTauntonUnited Kingdom12
Newcross HospitalWolverhamptonUnited Kingdom1
Norfolk and Norwich University HospitalNorwichUnited Kingdom8
North Middlesex HospitalLondonUnited Kingdom1
Nottingham City HospitalNottinghamUnited Kingdom1
Queen Elizabeth HospitalBirminghamUnited Kingdom3
Queen's HospitalRomfordUnited Kingdom3
Royal Devon and Exeter HospitalExeterUnited Kingdom6